Health and Life science
The ability of healthcare to cope with an ageing population, increasing chronic diseases and threats such as antibiotic resistance and pandemics will determine the future of public health. At the same time, digitalisation and new treatment methods are opening up completely new opportunities – but the path from innovation to clinical benefit requires both cutting-edge technical expertise and regulatory precision.
RISE supports companies, healthcare providers and municipalities throughout the entire development chain. This involves developing safe AI solutions for diagnostics and treatment, developing medicines and vaccines from concept to approved product, and validating medical devices in accordance with European regulations. In the field of infection control, RISE contributes with research and testing methods to combat antibiotic resistance and virus spread, while digital solutions and new working methods help the healthcare and care sector to adapt to future needs.
Explore the field of:
RISE Innovationspartnerskap - Omsorg
Blood typing for IVDR
EU reference laboratories
Microbiological risk assessment of product, process and production
How AI can revolutionise healthcare
TEF Health
CarePath
Accelerating the Home Care system
System change required to future-proof healthcare
Is an ageing population a problem or an opportunity? As the Swedish population ages, we need to find new ways to provide healthcare that is as good as or better than it is today.